Literature DB >> 25579068

Comments on Bang et al.: the impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.

E B Andrews1, A W Gilsenan, K D Midkiff, D H Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25579068     DOI： 10.1007/s00198-014-3003-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  3 in total

1.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

2.  The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.

Authors:  U C Bang; L Hyldstrup; J E B Jensen
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

3.  The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.

Authors:  Elizabeth B Andrews; Alicia W Gilsenan; Kirk Midkiff; Beth Sherrill; Yun Wu; Beth H Mann; Daniel Masica
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.